INSITE | Innovation, Science & Technology at SCRI
SCRI’s INSITE | Innovation, Science & Technology program integrates real-world data, AI-enabled technologies (Genospace), and deep scientific and operational expertise to enable more effective trial delivery.
We engage before a trial opens, with the Lead Management and Therapeutic Development teams reviewing study protocols for operational barriers and evaluating our site network for optimal placement. Once enrollment begins, our Personalized Medicine team identifies and reviews patient matches, extending the capabilities of site study teams. Throughout the trial lifecycle, the Business Intelligence and Program Development teams uncover opportunities to enhance efficiency and drive innovation.
By connecting data and technology across the clinical development lifecycle, INSITE accelerates the delivery of next-generation cancer therapies to patients.
INSITE and SCRI’s SMO
Partners with the site management organization (SMO) to build robust clinical trial menus and identify potential study candidates.
INSITE and SCRI’s CRO
Partners with SCRI’s contract research organization (CRO), Development Innovations, to enhance clinical development strategies and accelerate trial delivery.
Program Teams
Lead Management
shepherds clinical trial leads from the initial lead receipt all the way through the transition to the SMO Study Activation team. This team ensures that all necessary documents are carefully collected and that feasibility assessments and site selection are thoroughly completed, all to enable a smooth and efficient study start-up process.
Lead Management
shepherds clinical trial leads from the initial lead receipt all the way through the transition to the SMO Study Activation team. This team ensures that all necessary documents are carefully collected and that feasibility assessments and site selection are thoroughly completed, all to enable a smooth and efficient study start-up process.
Therapeutic Development
ensures that every trial entering the SCRI network is strategically designed and operationally positioned to succeed by aligning study design and site selection, and actively guiding performance across the full trial lifecycle.
Therapeutic Development
ensures that every trial entering the SCRI network is strategically designed and operationally positioned to succeed by aligning study design and site selection, and actively guiding performance across the full trial lifecycle.
Personalized Medicine
utilizes network-wide data and AI-powered technologies to identify and screen patients for trials.
Personalized Medicine
utilizes network-wide data and AI-powered technologies to identify and screen patients for trials.
Business Intelligence
transforms enterprise-wide data into actionable analytics and operational efficiencies.
Business Intelligence
transforms enterprise-wide data into actionable analytics and operational efficiencies.
INSITE Program Development
drives data and technology integration to promote innovation and accelerated trial delivery.
INSITE Program Development
drives data and technology integration to promote innovation and accelerated trial delivery.
How We Support Our Sites
